Skip to content

Passive Neurosensory Reintegration Training as a Tool to Augment Mild Traumatic Brain Injury

Passive Neurosensory Reintegration Training as a Tool to Augment Mild Traumatic Brain Injury

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07356167
Acronym
PNRT for mTBI
Enrollment
80
Registered
2026-01-21
Start date
2025-12-15
Completion date
2027-05-31
Last updated
2026-01-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Mild Traumatic Brain Injury

Keywords

mTBI, mild traumatic brain injury, TBI, visuo-vestibular dysfunction, vestibular dysfunction

Brief summary

Mild traumatic brain injury (mTBI) poses a substantial clinical and public health burden, often leading to persistent neurosensory and cognitive symptoms for which diagnostic and therapeutic solutions remain limited. This study proposes a multimodal diagnostic framework that integrates established mTBI screening tools and clinical neuro-optometric assessments with high-resolution oculomotor, vestibular, and reaction time (OVRT) testing to enhance diagnostic precision and identify prognostic markers of recovery. Normative data will be established in healthy controls to inform objective thresholds and support clinical implementation. Concurrently, we will evaluate the safety, tolerability, and preliminary efficacy of a novel, minimal-risk multisensory therapeutic intervention (i.e., passive neurosensory reintegration training, or PNRT) for individuals with sub-acute or chronic mTBI. By addressing critical gaps in both diagnosis and treatment, this project will improve mTBI recovery outcomes, inform future clinical trials, and advance evidence-based mTBI care guidelines.

Interventions

DEVICEPassive neurosensory reintegration training (PNRT)

PNRT is a non-invasive, device-based system that delivers synchronized visual, vestibular, auditory, and somatosensory stimulation. The system consists of a light box and motion platform. Participants remain supine while receiving filtered halogen light at \<10 lux intensity (non-laser, non-UV) synchronized with controlled stimuli.

Sponsors

University of Miami
Lead SponsorOTHER

Study design

Allocation
NON_RANDOMIZED
Intervention model
PARALLEL
Primary purpose
OTHER
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

1. Adults aged 18 or older 2. Clear mechanism of injury (i.e., direct or indirect impact to head), or Any individual presenting with complaints of sudden (\<24h) onset neurosensory symptoms as characterized by hearing a noise, feeling a force, or having an unexpected neurosensory perception and unexplained by any other known etiology ("sudden neurosensory events" or SNEs) 3. Glasgow Coma Scale (GCS) score of 13-15 at the time of injury 4. Observed or reported focal signs at the time of injury (e.g., loss of consciousness, amnesia, or confusion) or neurosensory symptoms (e.g., dizziness, headaches, photo/phonophobia, fatigue, vision problems, sleep changes, mood changes, cognitive fog) lasting over 4 weeks to 3 months (sub-acute), or over 3 months (chronic) following brain injury

Exclusion criteria

1. Any of the following: moderate to severe TBI characterized by penetrating head trauma, GCS \<13 at the time of injury, LOC \>30 minutes or PTA \>24 hours, subdural or epidural hemorrhage for most recent occurence 2. mTBI/SNE Group: History of 4 or more clinically diagnosed mTBIs that warranted emergent assessment in a hospital or emergency department setting Control Group: History of mTBI within the last 12 months or presence of mTBI-related symptoms at time of enrollment 3. Presence of severe aphasia 4. History of diagnosed psychiatric disorder or autoimmune/rheumatologic conditions prior to brain injury 1. Uncontrolled autoimmune/rheumatologic conditions including but not limited to Lyme, POTS, EDS, long COVID 2. Psychiatric disorders: including but not limited to severe depression, schizophrenia, lupus) 5. Documented neurological disorders (e.g., epilepsy, stroke, dementia) 6. Legally blind (characterized by a best-corrected visual acuity of 20/200 or less in the better eye or a visual field of 20 degrees or less) 7. History of tumor of the brain or central nervous system 8. Actively receiving vision therapy for current mTBI-related visual-impairment 9. Wards of the state or prisoners

Design outcomes

Primary

MeasureTime frameDescription
Change in Dizziness Handicap Inventory (DHI) Total ScoreBaseline to Day 13 (Post-Intervention)Within-subject change in DHI total score from baseline to Day 13 following Passive Neurosensory Reintegration Training (PNRT). The mean change will be reported with 95% confidence intervals. Additionally, the proportion of participants achieving ≥18-point reduction in DHI score will be calculated as having clinically meaningful improvement.

Countries

United States

Contacts

CONTACTErin Williams, Ph.D.
erin.williams@med.miami.edu305-243-8959

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026